These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3823741)

  • 1. [Evaluation of the therapeutic activity of albendazole in rats experimentally infected with Strongyloides venezuelensis].
    Amato Neto V; Pinto PL; Moreira AA; Campos R; de Sant'Ana EJ; Levai EV; Padilha LA; Takiguti CK
    Rev Inst Med Trop Sao Paulo; 1986; 28(3):181-4. PubMed ID: 3823741
    [No Abstract]   [Full Text] [Related]  

  • 2. Strongyloides ratti and S. stercoralis: the effects of thiabendazole, mebendazole, and cambendazole in infected mice.
    Grove DI
    Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):469-76. PubMed ID: 7081540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Strongyloidosis. Part IX. Treatment].
    Soroczan W
    Wiad Parazytol; 2002; 48(2):173-96. PubMed ID: 16888940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of thiabendazole, mebendazole and cambendazole in normal and immunosuppressed dogs infected with a human strain of Strongyloides stercoralis.
    Grove DI; Northern C
    Trans R Soc Trop Med Hyg; 1988; 82(1):146-9. PubMed ID: 3176142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cambendazole - a new substance for the treatment of strongyloidiasis].
    Huggins D
    G E N; 1979; 33(3-4):301-5. PubMed ID: 121988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delimitation of the anthelmintic activity of albendazole. Study concerning human strongyloidiasis].
    Amato Neto V; Moreira AA; Chiaramelli MC; Leme JM; Chiaramelli DR; Campos R; Pinto PL; de Sant'ana EJ; da Rocha ES
    Rev Inst Med Trop Sao Paulo; 1985; 27(2):95-8. PubMed ID: 3911347
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cambendazole--a new substance for the treatment of strongyloidiasis].
    Huggins D
    An Inst Hig Med Trop (Lisb); 1976; 4(1-4):151-3. PubMed ID: 1032470
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cambendazole: new anthelmintic in the therapy of strongyloidiasis. Clinical trial].
    Rodrigues LD; Martirani I; Cabeça M; Soares W; Brandão JA
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):57-67. PubMed ID: 331439
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations on development of Strongyloides westeri in foals nursing dams treated with cambendazole or thiabendazole.
    Lyons ET; Drudge JH; Tolliver SC
    Am J Vet Res; 1977 Jun; 38(6):889-92. PubMed ID: 879586
    [No Abstract]   [Full Text] [Related]  

  • 10. Albendazole and thiabendazole in murine strongyloidiasis.
    Mojon M; Saura C; Roojee N; Tran Manh Sung R
    J Antimicrob Chemother; 1987 Jan; 19(1):79-85. PubMed ID: 3558170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of intestinal helminthiasis with a new drug combination: cambendazole + mebendazole].
    Huggins D
    An Inst Hig Med Trop (Lisb); 1977-1978; 5(1-4):409-14. PubMed ID: 399826
    [No Abstract]   [Full Text] [Related]  

  • 12. Cambendazole in the treatment of human strongyloidiasis.
    Bicalho SA; Leão OJ; Pena Q
    Am J Trop Med Hyg; 1983 Sep; 32(5):1181-3. PubMed ID: 6625071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiment in using Vermox (mebendazole) for treating strongyloidiasis].
    Tikhomirova EP; Prokhorov AF
    Med Parazitol (Mosk); 1978; 47(4):26-8. PubMed ID: 355824
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of albendazole against Strongyloides ratti and S. stercoralis in vitro, in mice, and in normal and immunosuppressed dogs.
    Grove DI; Lumsden J; Northern C
    J Antimicrob Chemother; 1988 Jan; 21(1):75-84. PubMed ID: 3356624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary personal observations on the effectiveness of cambendazole in the treatment of strongyloidiasis].
    Amato Neto V; Sinto T; Pedro RJ; Levi GC; Tsukumo MK; Moraes VM; Corrêa LL
    Rev Inst Med Trop Sao Paulo; 1978; 20(3):161-3. PubMed ID: 684325
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of human strongyloidiasis with a new antihelmintic, cambendazole. Double-blind study].
    Baranski MC; da Silva AF; Kotaka PI; Gomes NR; Giovannoni M; Telles JE
    Rev Inst Med Trop Sao Paulo; 1978; 20(4):213-8. PubMed ID: 364600
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.
    Nontasut P; Muennoo C; Sa-nguankiat S; Fongsri S; Vichit A
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):442-4. PubMed ID: 15916052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the effectiveness of albendazole in the treatment of human strongyloidiasis].
    Domínguez Vázquez A; Corroy Navarro M; Coutiño Ocampo MC
    Bol Chil Parasitol; 1988; 43(3-4):61-3. PubMed ID: 3269729
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of human strongyloidiasis with cambendazole, a new anthelminthic. Double-blind study.
    Barański MC; da Silva AF; Kotaka PI; Gomes NR; Giovannoni M; Telles JE
    Mater Med Pol; 1983; 15(1-2):36-8. PubMed ID: 6400164
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of strongyloidiasis with mebendazole.
    Mravak S; Schopp W; Bienzle U
    Acta Trop; 1983 Mar; 40(1):93-4. PubMed ID: 6134460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.